Skip to main content

Diagnostic options Β· UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 196–210 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-4276
ARX Gene Early Infantile Epileptic Encephalopathy Type 1 Genetic Test

This genetic test identifies mutations in the ARX gene associated with Early Infantile Epileptic Encephalopathy Type 1 (EIEE1).

Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ARX gene sequence", "Copy Number Variants (CNVs) in ARX gene"]
Parameters
[]
Preparation
["No specific fasting required", "Continue prescribed medications unless advised otherwise by physician"]
Indications
["Suspected Early Infantile Epileptic Encephalopathy Type 1 (EIEE1)", "Neonatal-onset seizures with developmental delay"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81306-1 ICD-10: G40.4
Clinical summary
This genetic test identifies mutations in the ARX gene associated with Early Infantile Epileptic Encephalopathy Type 1 (EIEE1).
TEST-2637
ARX Gene Lissencephaly (X-linked Type 2) NGS Test

This test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly type 2 and related brain malformations.

Peripheral Whole Blood or Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ARX gene pathogenic variants", "Nucleotide substitutions", "Small indels", "Copy number variations"]
Parameters
[]
Preparation
[]
Indications
["Male infants with lissencephaly", "Infantile spasms", "Developmental delay confirmed by brain MRI"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94243-9 ICD-10: Q04.3
Clinical summary
This test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly type 2 and related brain malformations.
TEST-5541
ARX Gene Partington Syndrome Genetic Test

This test sequences the ARX gene to detect pathogenic variants associated with Partington syndrome.

Peripheral Whole Blood (3-5 mL in EDTA) or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ARX gene sequence", "Pathogenic variants in ARX gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of all current medications"]
Indications
["Suspected ARX-related Partington syndrome", "X-linked intellectual disability", "Family history of Partington syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 10386-3 ICD-10: Q87.8
Clinical summary
This test sequences the ARX gene to detect pathogenic variants associated with Partington syndrome.
TEST-4525
ARX Gene Sequencing (Hydranencephaly with Abnormal Genitalia / X‑Linked Lissencephaly Typeβ€―2) Genetic Test

This genetic test sequences the ARX gene to identify pathogenic variants associated with specific neurodevelopmental disorders.

Whole blood, extracted DNA, or one drop on FTA card 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ARX gene sequence", "Pathogenic variants (SNPs, indels, CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Suspected ARX-related disorders", "Diagnosis confirmation", "Prognosis determination", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21641-2 ICD-10: Q04.2, Q04.8, Q87.0
Clinical summary
This genetic test sequences the ARX gene to identify pathogenic variants associated with specific neurodevelopmental disorders.
TEST-2937
ARX Gene-Associated Agenesis of Corpus Callosum with Abnormal Genitalia (XLAG) Genetic Test

This diagnostic test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly with ambiguous genitalia (XLAG) syndrome and related neurological conditi...

Peripheral whole blood (3–5 mL venipuncture) or finger-prick blood spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ARX gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Intragenic Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your doctor"]
Indications
["Individuals with clinical features suggestive of XLAG syndrome", "Family screening for ARX-related disorders", "Prenatal or preimplantation genetic diagnosis options"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 80230-8 ICD-10: Q04.0
Clinical summary
This diagnostic test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly with ambiguous genitalia (XLAG) syndrome and related neurological conditions.
TEST-5731
ASAH1 Gene Sequencing for Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME) Test

This test detects pathogenic variants in the ASAH1 gene associated with Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME).

Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ASAH1 gene", "Copy Number Variations (CNV) in the ASAH1 gene"]
Parameters
[]
Preparation
["No specific fasting required", "No medication adjustments needed prior to sample collection"]
Indications
["Suspected diagnosis of SMA-PME", "Patients with hallmark symptoms of myoclonus and motor regression"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81260-9 ICD-10: G12.1, G40.3
Clinical summary
This test detects pathogenic variants in the ASAH1 gene associated with Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME).
TEST-3994
ASCL1 Gene Central Hypoventilation Syndrome (Congenital) Genetic Test

This test identifies pathogenic variants in the ASCL1 gene associated with Congenital Central Hypoventilation Syndrome (CCHS). It uses Next-Generation Sequencing (NGS) for comprehe...

Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot 21–28 Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ASCL1 gene", "Single nucleotide variants (SNVs)", "Small insertions or deletions (indels)", "Large copy number variants (deletions/duplications)"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustments required"]
Indications
["Clinical suspicion of Congenital Central Hypoventilation Syndrome (CCHS)", "Individuals with unexplained alveolar hypoventilation or autonomic dysregulation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94219-7 ICD-10: G47.69
Clinical summary
This test identifies pathogenic variants in the ASCL1 gene associated with Congenital Central Hypoventilation Syndrome (CCHS). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-3001
ASCL1 Gene Central Hypoventilation Syndrome, Congenital Test

This diagnostic test evaluates the ASCL1 gene for pathogenic variants associated with Congenital Central Hypoventilation Syndrome (CCHS). It identifies disease-causing mutations li...

Whole Blood (EDTA), Extracted DNA, FTA Card (One Drop) 3 to 4 Weeks (Expedited Processing Available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ASCL1 gene", "Full coding exons and flanking intronic regions of ASCL1"]
Parameters
[{"name": "Analytical Sensitivity", "reference_range": "99.9%"}, {"name": "Analytical Specificity", "reference_range": "99.9%"}, {"name": "Mean Read Depth", "reference_range": "100x"}]
Preparation
["No specific fasting required", "Inform laboratory of any medications that may compromise DNA integrity"]
Indications
["Suspected Congenital Central Hypoventilation Syndrome (CCHS)", "Neonates and paediatric patients with abnormal respiratory control", "Family planning decisions related to CCHS risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92824-5 ICD-10: G47.35
Clinical summary
This diagnostic test evaluates the ASCL1 gene for pathogenic variants associated with Congenital Central Hypoventilation Syndrome (CCHS). It identifies disease-causing mutations linked to Ondine's Curse.
TEST-2558
ASPM Gene Microcephaly Autosomal Recessive Type 5 Genetic Test

This genetic test identifies pathogenic variants in the ASPM gene associated with autosomal recessive primary microcephaly type 5 (MCPH5). It utilizes next-generation sequencing (N...

Peripheral whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ASPM gene", "Single-nucleotide variants (SNVs)", "Copy-number variations (CNVs)"]
Parameters
[{"name": "ASPM Gene Variants", "reference_range": "No pathogenic variants detected"}]
Preparation
["No specific fasting required", "Inform phlebotomist of any bleeding disorders or medications"]
Indications
["Clinical suspicion of autosomal recessive primary microcephaly type 5 (MCPH5)", "Family history of MCPH5", "Genetic counselling for families with microcephaly"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94809-4 ICD-10: Q02
Clinical summary
This genetic test identifies pathogenic variants in the ASPM gene associated with autosomal recessive primary microcephaly type 5 (MCPH5). It utilizes next-generation sequencing (NGS) to detect single-nucleotide variants and copy-number variations.
TEST-6212
ASS1 Gene Citrullinemia Genetic Test

This test identifies mutations in the ASS1 gene associated with citrullinemia type I, a urea cycle disorder.

Whole blood (EDTA) or FTA card (dried blood spot) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ASS1 gene pathogenic variants", "Urea cycle disorder risk"]
Parameters
[]
Preparation
["Do not discontinue prescribed treatments", "Inform physician of recent blood transfusions"]
Indications
["Suspected citrullinemia type I", "Family history of urea cycle disorders", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76016-2 ICD-10: E72.2
Clinical summary
This test identifies mutations in the ASS1 gene associated with citrullinemia type I, a urea cycle disorder.
TEST-3671
Ataxia Genetic Test)

This test identifies genetic mutations associated with various forms of hereditary ataxia.

Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) 3–4 Weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in ataxia-related genes", "Copy Number Variations (CNVs) in ataxia-related genes"]
Parameters
[]
Preparation
["Fasting is not required", "Provide a list of current medications and supplements", "No supplements or drugs need to be discontinued"]
Indications
["Diagnosis of suspected hereditary ataxia", "Predictive testing for individuals with family history", "Carrier screening", "Family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92195-6 ICD-10: G11.9, G11.0, G11.1, G11.2, G11.3, G11.4, G11.8
Clinical summary
This test identifies genetic mutations associated with various forms of hereditary ataxia.
TEST-3696
Ataxia Repeat Expansion Panel (Genetic Test)

This test detects pathogenic repeat expansions in genes linked to hereditary ataxias.

Peripheral whole blood (EDTA) or FTA card 3–4 Weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic repeat expansions", "Gene mutations associated with ataxia"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustments needed"]
Indications
["Suspected hereditary ataxia", "Family history of ataxia", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92857-7 ICD-10: G11.0, G11.1, G11.2, G11.3, G11.4, G11.8, G11.9
Clinical summary
This test detects pathogenic repeat expansions in genes linked to hereditary ataxias.
TEST-2727
Ataxia-Telangiectasia Genetic Testing (NGS with Sanger Confirmation) Test

This test identifies pathogenic variants in the ATM gene, confirming a diagnosis of Ataxia-Telangiectasia.

Peripheral whole blood (Lavender-top EDTA tubes) 40 working days 2,600.00 AED
View
View test specifications and preparation
What it measures
["ATM gene variants", "Single-nucleotide variants", "Small insertions/deletions", "Exon-level copy-number changes"]
Parameters
[]
Preparation
["Do not discontinue prescribed therapy without physician instruction", "Testing in children requires prior clinical assessment by a specialist"]
Indications
["Suspected Ataxia-Telangiectasia", "Progressive cerebellar ataxia", "Immunodeficiency", "Elevated cancer risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92041-1 ICD-10: G11.3
Clinical summary
This test identifies pathogenic variants in the ATM gene, confirming a diagnosis of Ataxia-Telangiectasia.
TEST-5741
Ataxin-10 (ATXN10) Gene Spinocerebellar Ataxia Typeβ€―10 Autosomal Dominant Genetic Test

This genetic test identifies the specific pentanucleotide repeat expansion in the ATXN10 gene associated with Spinocerebellar Ataxia Type 10 (SCA10).

Whole blood (3–5 mL in EDTA), extracted DNA, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ATXN10 gene pentanucleotide repeat expansion", "Pathogenic variant detection"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Clinical suspicion of hereditary ataxia", "Confirmed family history of SCA10", "Genetic counseling for at-risk individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: G11.2
Clinical summary
This genetic test identifies the specific pentanucleotide repeat expansion in the ATXN10 gene associated with Spinocerebellar Ataxia Type 10 (SCA10).
TEST-6072
ATIC Gene AICA-Ribosiduria due to ATIC Deficiency Genetic Test

This genetic test identifies pathogenic variants in the ATIC gene associated with AICA-ribosiduria, an autosomal recessive disorder of purine metabolism.

Whole Blood (EDTA) or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ATIC gene"]
Parameters
[]
Preparation
["Mandatory genetic counselling session", "Provide complete clinical history", "No fasting required"]
Indications
["Diagnosis of AICA-ribosiduria", "Carrier screening for AICA-ribosiduria", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: E79.8
Clinical summary
This genetic test identifies pathogenic variants in the ATIC gene associated with AICA-ribosiduria, an autosomal recessive disorder of purine metabolism.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area